What is www.gbipharma.com?
www.gbipharma.com is website that delivers China-focused content developed by GBI for the pharmaceutical industry. The information includes reports, databases, and news relevant for research and development, competitor tracking, partnership, market research, and government relations.

What is GB Information?
GBI is the information division of General Biologic. The company is based in Shanghai.

Who benefits from GBI's information?
Pharmaceutical companies, professional services firms, industry analysts, and vendors to the pharmaceutical industry benefit from access. Within pharmaceutical companies, senior management, business development, licensing, marketing, product management, research and development, and numerous other departments and functions rely on GBI.

How does GBI collect information?
GBI conducts secondary research as well as primary research in order to generate our news, databases, and reports. GBI relies especially heavily on primary research as we believe this is essential to creating high quality information in China. Much of the information in the public domain is inaccurate or misleading.

What makes GBI different from companies like Google and Factiva?
GBI creates its own content through secondary and primary means. We have people on the ground talking with companies, engaged in the industry, and in constant communication with insiders and thought leaders. We write the reports, populate the databases, and create content. Third-party content is incorporated into our products and services, but only after a lengthy verification and value-add procedure. GBI believes in industry focused content delivery. Gbipharma.com provides information required by pharmaceutical companies, allowing us to be laser focused on customer needs.

What makes GBI different from companies like Informa, Datamonitor, and CHA?
GBI's analysts are on the ground and focus on the pharmaceutical industry as a full time job. GBI's entire operation is in China, with a bilingual staff drawn from industry. Most multinational information providers rely exclusively on public information and third party vendors and usually create generic information products which they then sell to clients, often at high price points.

What makes GBI different than IMS Health?
IMS Health focuses on prescription data and sales force effectiveness consulting. GBI provides a much broader information platform including research and development, competitor, and market data, analysis, and recommendations. GBI does not currently provide prescription data.

Does GBI provide consulting services?
Yes. Please contact us to discuss specific projects.

Does GBI provide any additional functionality through its website?
Yes. Premium subscribers can request meetings with third parties and may request detailed company profiles be created within 48 hours through our website.

How do I purchase information from GBI?
Individual reports and subscriptions to databases are available for purchase through our website. For multi-user or multi-database and report access, please see our solutions.

How often are GBI's databases updated?
Each database is updated on a different schedule depending upon the frequency of change of information and customer needs. All of the databases are updated at least once per year and some are updated daily.

In what areas will GBI expand its content over the short and medium term?
GBI seeks to provide a total information solution for pharmaceutical companies. Our intent is to maintain our dominant position in R&D and greatly expand our offerings in patient, physician, hospital, market, competitor, and policy information.

Does GBI provide information for countries other than China?
Not yet.

Does GBIprovide information for industries other than pharmaceutical?
Not yet.

Can I have a look at a database before I purchase?
Registration on our website results in free access to the China life scientists database and a number of presentations and white papers. For other products, please contact us to request a walk through.